{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T18:48:48Z","timestamp":1794768528184,"version":"4.9.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T00:00:00Z","timestamp":1528070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Key Basic Research Program (973) of China","award":["2015CB554202"],"award-info":[{"award-number":["2015CB554202"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81401643"],"award-info":[{"award-number":["81401643"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"State Key Research Development Program of China","award":["2016YFC1200301"],"award-info":[{"award-number":["2016YFC1200301"]}]},{"name":"science and technology plan program of Beijing, China","award":["Z151100003915151"],"award-info":[{"award-number":["Z151100003915151"]}]},{"name":"State Key Laboratory of Pathogen and Biosecurity Program","award":["SKLPBS1530"],"award-info":[{"award-number":["SKLPBS1530"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3101-1","type":"journal-article","created":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T09:42:47Z","timestamp":1528105367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Clinical and bacteriological features and prognosis of ascitic fluid infection in Chinese patients with cirrhosis"],"prefix":"10.1186","volume":"18","author":[{"given":"Nian-zhi","family":"Ning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-liang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Huan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-mei","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,4]]},"reference":[{"key":"3101_CR1","doi-asserted-by":"crossref","unstructured":"Arvaniti V, D\u2019Amico G, Fede G, Manousou P, Tsochatzis E, Pleguezuelo M, Burroughs AK: Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology 2010, 139(4):1246\u20131256, 1256.e1241\u20131245.","DOI":"10.1053\/j.gastro.2010.06.019"},{"issue":"3","key":"3101_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","volume":"53","author":"European Association for the Study of the L","year":"2010","unstructured":"European Association for the Study of the L. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53(3):397\u2013417.","journal-title":"J Hepatol"},{"issue":"4","key":"3101_CR3","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/S0168-8278(00)80221-4","volume":"32","author":"E Ricart","year":"2000","unstructured":"Ricart E, Soriano G, Novella MT, Ortiz J, Sabat M, Kolle L, Sola-Vera J, Minana J, Dedeu JM, Gomez C, et al. Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients. J Hepatol. 2000;32(4):596\u2013602.","journal-title":"J Hepatol"},{"issue":"1","key":"3101_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/340617","volume":"35","author":"B Campillo","year":"2002","unstructured":"Campillo B, Richardet JP, Kheo T, Dupeyron C. Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection. Clin Infect Dis. 2002;35(1):1\u201310.","journal-title":"Clin Infect Dis"},{"issue":"17","key":"3101_CR5","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.3748\/wjg.14.2757","volume":"14","author":"S Angeloni","year":"2008","unstructured":"Angeloni S, Leboffe C, Parente A, Venditti M, Giordano A, Merli M, Riggio O. Efficacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice. World J Gastroenterol. 2008;14(17):2757\u201362.","journal-title":"World J Gastroenterol"},{"issue":"10","key":"3101_CR6","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1111\/j.1365-2036.2012.05076.x","volume":"35","author":"PA Reuken","year":"2012","unstructured":"Reuken PA, Pletz MW, Baier M, Pfister W, Stallmach A, Bruns T. Emergence of spontaneous bacterial peritonitis due to enterococci - risk factors and outcome in a 12-year retrospective study. Aliment Pharmacol Ther. 2012;35(10):1199\u2013208.","journal-title":"Aliment Pharmacol Ther"},{"key":"3101_CR7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/1471-2334-14-287","volume":"14","author":"L Piroth","year":"2014","unstructured":"Piroth L, Pechinot A, Di Martino V, Hansmann Y, Putot A, Patry I, Hadou T, Jaulhac B, Chirouze C, Rabaud C, et al. Evolving epidemiology and antimicrobial resistance in spontaneous bacterial peritonitis: a two-year observational study. BMC Infect Dis. 2014;14:287.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"3101_CR8","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/hep.25532","volume":"55","author":"J Fernandez","year":"2012","unstructured":"Fernandez J, Acevedo J, Castro M, Garcia O, de Lope CR, Roca D, Pavesi M, Sola E, Moreira L, Silva A, et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology. 2012;55(5):1551\u201361.","journal-title":"Hepatology"},{"issue":"7","key":"3101_CR9","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1111\/liv.12152","volume":"33","author":"A Alexopoulou","year":"2013","unstructured":"Alexopoulou A, Papadopoulos N, Eliopoulos DG, Alexaki A, Tsiriga A, Toutouza M, Pectasides D. Increasing frequency of gram-positive cocci and gram-negative multidrug-resistant bacteria in spontaneous bacterial peritonitis. Liver Int. 2013;33(7):975\u201381.","journal-title":"Liver Int"},{"issue":"25","key":"3101_CR10","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.3748\/wjg.v23.i25.4654","volume":"23","author":"M Fiore","year":"2017","unstructured":"Fiore M, Maraolo AE, Gentile I, Borgia G, Leone S, Sansone P, Passavanti MB, Aurilio C, Pace MC. Nosocomial spontaneous bacterial peritonitis antibiotic treatment in the era of multi-drug resistance pathogens: A systematic review. World J Gastroenterol. 2017;23(25):4654\u201360.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"3101_CR11","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/hep.27406","volume":"60","author":"FS Wang","year":"2014","unstructured":"Wang FS, Fan JG, Zhang Z, Gao B, Wang HY. The global burden of liver disease: the major impact of China. Hepatology. 2014;60(6):2099\u2013108.","journal-title":"Hepatology"},{"issue":"36","key":"3101_CR12","doi-asserted-by":"publisher","first-page":"10409","DOI":"10.3748\/wjg.v21.i36.10409","volume":"21","author":"YT Li","year":"2015","unstructured":"Li YT, Yu CB, Huang JR, Qin ZJ, Li LJ. Pathogen profile and drug resistance analysis of spontaneous peritonitis in cirrhotic patients. World J Gastroenterol. 2015;21(36):10409\u201317.","journal-title":"World J Gastroenterol"},{"issue":"10","key":"3101_CR13","first-page":"1152","volume":"31","author":"YZ Gou","year":"2010","unstructured":"Gou YZ, Liu B, Pan L, Yu HT, Wang JP, Wang DC. Pathogens of spontaneous bacterial peritonitis change in northern China. Saudi medical journal. 2010;31(10):1152\u20136.","journal-title":"Saudi medical journal"},{"issue":"6","key":"3101_CR14","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1002\/hep.22853","volume":"49","author":"BA Runyon","year":"2009","unstructured":"Runyon BA. Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009;49(6):2087\u2013107.","journal-title":"Hepatology"},{"issue":"1","key":"3101_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S0168-8278(00)80201-9","volume":"32","author":"A Rimola","year":"2000","unstructured":"Rimola A, Garcia-Tsao G, Navasa M, Piddock LJ, Planas R, Bernard B, Inadomi JM. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol. 2000;32(1):142\u201353.","journal-title":"J Hepatol"},{"issue":"2","key":"3101_CR16","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1053\/jhep.2001.22172","volume":"33","author":"PS Kamath","year":"2001","unstructured":"Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464\u201370.","journal-title":"Hepatology"},{"issue":"11","key":"3101_CR17","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.cgh.2010.06.024","volume":"8","author":"M Merli","year":"2010","unstructured":"Merli M, Lucidi C, Giannelli V, Giusto M, Riggio O, Falcone M, Ridola L, Attili AF, Venditti M. Cirrhotic patients are at risk for health care-associated bacterial infections. Clin Gastroenterol Hepatol. 2010;8(11):979\u201385.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3101_CR18","unstructured":"Wayne PA. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-ninth edition M07-A9. CLSI. 2012;"},{"issue":"9","key":"3101_CR19","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1086\/597585","volume":"48","author":"HS Cheong","year":"2009","unstructured":"Cheong HS, Kang CI, Lee JA, Moon SY, Joung MK, Chung DR, Koh KC, Lee NY, Song JH, Peck KR. Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis. Clin Infect Dis. 2009;48(9):1230\u20136.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"3101_CR20","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/BF02064369","volume":"40","author":"CM Chu","year":"1995","unstructured":"Chu CM, Chang KY, Liaw YF. Prevalence and prognostic significance of bacterascites in cirrhosis with ascites. Dig Dis Sci. 1995;40(3):561\u20135.","journal-title":"Dig Dis Sci"},{"issue":"4 Pt 1","key":"3101_CR21","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/hep.1840120415","volume":"12","author":"BA Runyon","year":"1990","unstructured":"Runyon BA. Monomicrobial nonneutrocytic bacterascites: a variant of spontaneous bacterial peritonitis. Hepatology. 1990;12(4 Pt 1):710\u20135.","journal-title":"Hepatology"},{"issue":"9","key":"3101_CR22","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1038\/ajg.2013.204","volume":"108","author":"P Tandon","year":"2013","unstructured":"Tandon P, Kumar D, Seo YS, Chang HJ, Chaulk J, Carbonneau M, Qamar H, Keough A, Mansoor N, Ma M. The 22\/11 risk prediction model: a validated model for predicting 30-day mortality in patients with cirrhosis and spontaneous bacterial peritonitis. Am J Gastroenterol. 2013;108(9):1473\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"3101_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3350\/cmh.2013.19.2.131","volume":"19","author":"PC Tsung","year":"2013","unstructured":"Tsung PC, Ryu SH, Cha IH, Cho HW, Kim JN, Kim YS, Moon JS. Predictive factors that influence the survival rates in liver cirrhosis patients with spontaneous bacterial peritonitis. Clin Mol Hepatol. 2013;19(2):131\u20139.","journal-title":"Clin Mol Hepatol"},{"key":"3101_CR24","doi-asserted-by":"crossref","unstructured":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. Journal of hepatology 2010, 53(3):397\u2013417.","DOI":"10.1016\/j.jhep.2010.05.004"},{"issue":"6","key":"3101_CR25","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.cgh.2012.02.026","volume":"10","author":"TH Hung","year":"2012","unstructured":"Hung TH, Tsai CC, Hsieh YH, Tsai CC, Tseng CW, Tsai JJ. Effect of renal impairment on mortality of patients with cirrhosis and spontaneous bacterial peritonitis. Clin Gastroenterol Hepatol. 2012;10(6):677\u201381.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"3101_CR26","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jhep.2011.11.010","volume":"56","author":"X Ariza","year":"2012","unstructured":"Ariza X, Castellote J, Lora-Tamayo J, Girbau A, Salord S, Rota R, Ariza J, Xiol X. Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis. J Hepatol. 2012;56(4):825\u201332.","journal-title":"J Hepatol"},{"issue":"1","key":"3101_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s15010-008-8060-9","volume":"37","author":"A Umgelter","year":"2009","unstructured":"Umgelter A, Reindl W, Miedaner M, Schmid RM, Huber W. Failure of current antibiotic first-line regimens and mortality in hospitalized patients with spontaneous bacterial peritonitis. Infection. 2009;37(1):2\u20138.","journal-title":"Infection"},{"issue":"9","key":"3101_CR28","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1097\/00042737-200509000-00008","volume":"17","author":"F Bert","year":"2005","unstructured":"Bert F, Noussair L, Lambert-Zechovsky N, Valla D. Viridans group streptococci: an underestimated cause of spontaneous bacterial peritonitis in cirrhotic patients with ascites. Eur J Gastroenterol Hepatol. 2005;17(9):929\u201333.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"3101_CR29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10096-003-1078-0","volume":"23","author":"S Harbarth","year":"2004","unstructured":"Harbarth S, Uckay I. Are there patients with peritonitis who require empiric therapy for enterococcus? Eur J Clin Microbiol Infect Dis. 2004;23(2):73\u20137.","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3101-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-3101-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3101-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T19:03:44Z","timestamp":1559588624000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3101-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,4]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3101"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3101-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,4]]},"assertion":[{"value":"8 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was reviewed and approved by the Beijing 302 Hospital Research Ethics Committee. The Beijing 302 Hospital Research Ethics Committee waived the need for written informed consent from the participants due to the de-identified secondary data analyzed in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"253"}}